Induction Therapy In Heart Transplantation: Is There A Role?
Authors:
- Patricia A. UberPUPatricia A. Uber
- Mandeep R. MehraMMMandeep R. Mehra
- 31 March 2007
- journal article
- editorial
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 26 (3) , 205-209
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Registry of the International Society for Heart and Lung Transplantation: Twenty-third Official Adult Heart Transplantation Report—2006The Journal of Heart and Lung Transplantation, 2006
- A Randomized Multicenter Comparison of Basiliximab and Muromonab (OKT3) in Heart Transplantation: SIMCOR StudyTransplantation, 2006
- A Multicenter, Prospective, Randomized, Double-Blind Trial of Basiliximab in Heart TransplantationThe Journal of Heart and Lung Transplantation, 2005
- Daclizumab to Prevent Rejection after Cardiac TransplantationNew England Journal of Medicine, 2005
- Risk/benefit ratio of perioperative OKT3 in cardiac transplantationThe American Journal of Cardiology, 1994
- A PROSPECTIVE RANDOMIZED STUDY OF PROPHYLACTIC OKT3 VERSUS EQUINE ANTITHYMOCYTE GLOBULIN AFTER HEART TRANSPLANTATION-INCREASED MORBIDITY WITH OKT3Transplantation, 1993
- Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant RecipientsNew England Journal of Medicine, 1990
- RELATIONSHIP OF OKT3 SENSITIZATION AND VASCULAR REJECTION IN CARDIAC TRANSPLANT PATIENTS RECEIVING OKT3 REJECTION PROPHYLAXISTransplantation, 1990
- Prophylactic therapy for rejection after cardiac transplantationThe Journal of Thoracic and Cardiovascular Surgery, 1990
- OKT3 Monoclonal Antibody in Cardiac TransplantationAnnals of Surgery, 1988